RMMPF.US RAMM Pharma Corp.
- Market cap
- -
- P/E
- -
- P/B
- 0.18x
- ROE
- -68.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jul 2026.
Is RMMPF.US undervalued?
Graham numberThe Graham number of RAMM Pharma Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RAMM Pharma Corp. fundamental analysis
No fundamental analysis for RAMM Pharma Corp. yet.
RAMM Pharma Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RAMM Pharma Corp.
RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC …
Full company profileRAMM Pharma Corp. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
RAMM Pharma Corp. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 3.90M | 5.07M | 4.34M | 3.36M | 884K |
| Gross Profit | 531K | 394K | 1.76M | 1.07M | 366K |
| Operating Income | -7.93M | -7.07M | -6.75M | -4.29M | -3.64M |
| EBITDA | -19.9M | -6.32M | -15.2M | -7.92M | -2.09M |
| Net Income | -21.0M | -7.72M | -16.5M | -8.91M | -2.56M |
| EPS | -0.17 | -0.06 | -0.14 | -0.07 | -0.02 |
| Balance Sheet | |||||
| Total Assets | 39.2M | 32.3M | 16.7M | 9.27M | 6.72M |
| Total Liabilities | 3.66M | 2.84M | 3.11M | 3.57M | 2.97M |
| Shareholders' Equity | 35.6M | 29.5M | 13.6M | 5.70M | 3.75M |
| Cash & Short-term Investments | 9.77M | 5.12M | 814K | 804K | 147K |
| Cash Flow | |||||
| Operating Cash Flow | -5.91M | -4.34M | -4.00M | -1.06M | -1.57M |
| Capital Expenditure | 168K | 62.2K | 47.4K | 0.00 | 0.00 |
| Free Cash Flow | -6.08M | -4.40M | -4.05M | -1.06M | -1.57M |
| Ratios | |||||
| ROE | -58.9% | -26.2% | -121.0% | -156.4% | -68.4% |
| ROA | -53.4% | -23.9% | -98.5% | -96.1% | -38.2% |
| Net Profit Margin | -537.8% | -152.4% | -380.1% | -265.1% | -289.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
RAMM Pharma Corp. dividends
RAMM Pharma Corp. has not paid dividends in the last 4 fiscal years.
Who owns RAMM Pharma Corp.
- Insiders 31.43%
- Institutions 0.00%
- Public & others 68.57%
- Free float 81.9M
RAMM Pharma Corp. company profile
- Company name
- RAMM Pharma Corp.
- Ticker
- RMMPF.US
- Exchange
- USA Stocks
- Sector
- -
- Industry
- -
- Fiscal year end
- October
- Address
- 200, 82 Richmond St. East, Toronto, ON, Canada, M5C 1P1
- Phone
- 416-848-7744
- Website
- wearerammpharma.com
About RAMM Pharma Corp.
RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
RAMM Pharma Corp. management
2- Mr. Jackie Peter BurnettPresident, CEO & Chairman
- Mr. Jose RoldanInterim CFO & Corporate Secretary